ARCHIVES

$14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists

This article is from The Cancer Letter archive.

Vol. 22 No. 41 | October 24, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

CCOP RFA Response So Far Points To More Consortia Applications, Reasonable Geographic Distribution

August 20, 1982

Grantees Seek $433.5 Million for construction

November 17, 1978

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

February 15, 1991

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008